{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:21:19Z","timestamp":1793924479008,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.radonc.2024.110199","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T11:16:50Z","timestamp":1709378210000},"page":"110199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Less than whole uterus irradiation for patients with locally advanced cervical cancer"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3864-4720","authenticated-orcid":false,"given":"Caressa","family":"Hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Ewongwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0062-3131","authenticated-orcid":false,"given":"Scott","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5489-2732","authenticated-orcid":false,"given":"Jie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110199_b0005","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians. 2023;73(1):17-48. doi:10.3322\/caac.21763.","DOI":"10.3322\/caac.21763"},{"key":"10.1016\/j.radonc.2024.110199_b0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0015","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and Para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90\u201301","volume":"22","author":"Eifel","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0020","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.ajog.2007.08.003","article-title":"RADIATION therapy with or without weekly cisplatin for bulky stage ib cervical carcinoma; follow-up of a gynecologic oncology group trial","volume":"197","author":"Stehman","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.radonc.2024.110199_b0025","doi-asserted-by":"crossref","unstructured":"Mileshkin LR, Moore KN, Barnes E, et al. Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274). JCO. 2021;39(18_suppl):LBA3-LBA3. doi:10.1200\/JCO.2021.39.15_suppl.LBA3.","DOI":"10.1200\/JCO.2021.39.15_suppl.LBA3"},{"key":"10.1016\/j.radonc.2024.110199_b0030","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and Para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110199_b0035","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0040","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110199_b0045","unstructured":"NCCN Cervical Cancer Guidelines. NCCN Guidelines. Accessed August 23, 2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf."},{"key":"10.1016\/j.radonc.2024.110199_b0050","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0055","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0060","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2009.06.041","article-title":"Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer","volume":"77","author":"Kidd","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110199_b0065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2006.12.023","article-title":"Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer","volume":"68","author":"Beriwal","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110199_b0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ygyno.2005.12.044","article-title":"Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix","volume":"102","author":"Gerszten","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0075","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.ijrobp.2006.02.041","article-title":"Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies","volume":"65","author":"Salama","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110199_b0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2009.10.075","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer","volume":"79","author":"Lim","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110199_b0085","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP. Accessed August 23, 2023. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_60."},{"key":"10.1016\/j.radonc.2024.110199_b0090","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1200\/JCO.20.02530","article-title":"Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial","volume":"39","author":"Chopra","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13014-018-1126-7","article-title":"Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis","volume":"13","author":"Lin","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0100","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG oncology-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0105","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/j.prro.2018.10.009","article-title":"Less than whole uterus irradiation for locally advanced cervical cancer maintains locoregional control and decreases radiation dose to bowel","volume":"9","author":"Kozak","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0110","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ijrobp.2009.02.044","article-title":"Does the entire uterus need to be treated in cancer of the cervix? role of adaptive brachytherapy","volume":"76","author":"Anker","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110199_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2013.02.005","article-title":"Dose to the non-involved uterine corpus with MRI guided brachytherapy in locally advanced cervical cancer","volume":"107","author":"Sapru","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110199_b0120","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s00330-010-1998-x","article-title":"Staging of uterine cervical cancer with MRI: guidelines of the european Society of Urogenital Radiology","volume":"21","author":"Balleyguier","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2024.110199_b0125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.mric.2017.03.007","article-title":"MR imaging of cervical cancer","volume":"25","author":"Patel-Lippmann","year":"2017","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.radonc.2024.110199_b0135","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/0360-3016(95)00262-W","article-title":"Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment now!","volume":"32","author":"Bentzen","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110199_b0140","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1186\/s12885-018-4800-0","article-title":"EXclusion of non-involved uterus from the target volume (EXIT-trial): an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques","volume":"18","author":"Vandecasteele","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2024.110199_b0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s13244-017-0567-0","article-title":"The value of advanced MRI techniques in the assessment of cervical cancer: a review","volume":"8","author":"Dappa","year":"2017","journal-title":"Insights Imaging"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400121X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400121X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:30:04Z","timestamp":1759123804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402400121X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":28,"alternative-id":["S016781402400121X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110199","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Less than whole uterus irradiation for patients with locally advanced cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110199"}}